Novel human TEF-1 isoforms exhibit altered DNA binding and functional properties.

Area of Science:

• Molecular Biology
• Gene Regulation
• Protein Isoforms

Background:

• Transcriptional enhancer factor-1 (TEF-1) is a TEA/ATTS domain transcription factor.
• TEF-1 binds to specific DNA elements (GT-IIC, SphI, SphII, M-CAT) and regulates genes like SV40 T antigen, muscle-specific genes, and hCS.
• TEF-1 can act as a transcriptional repressor, potentially by interacting with TATA binding protein (TBP).

Purpose of the Study:

• To clone and characterize two novel TEF-1 isoforms: TEF-1beta and TEF-1gamma.
• To investigate the tissue-specific expression patterns of these new isoforms.
• To functionally analyze the DNA binding and transcriptional activities of TEF-1beta and TEF-1gamma.

Main Methods:

• Cloning of novel TEF-1 isoforms.
• Analysis of tissue-specific expression patterns.
• Functional characterization of DNA binding affinity and transcriptional activity.

Main Results:

• TEF-1beta and TEF-1gamma were identified, likely arising from alternative mRNA splicing.
• TEF-1beta shows wide distribution, similar to TEF-1alpha, while TEF-1gamma has a restricted pattern (pancreas, kidney, muscle).
• TEF-1beta and TEF-1gamma display higher affinity for GT-IIC sequences and more efficient repression of the hCS promoter compared to TEF-1alpha.

Conclusions:

• Alternative splicing generates TEF-1 isoforms with distinct functional properties.
• TEF-1beta and TEF-1gamma possess altered DNA-binding and transcriptional regulatory capabilities.
• These isoforms likely mediate unique biological functions in specific tissues.